http://hdl.handle.net/1887/30223

exploring the role of glucagon in glucose homeostasis
114
van dongen mg, geerts bf, morgan es, brandt ta, de kam ml, romijn ja, cohen af, bhanot s, burggraaf j.
First proof of pharmacology in humans of a novel glucagon receptor antisense drug. J Clin Pharmacol. 2014 Sep 6.
[Epub ahead of print] van dongen mg, geerts bf, bhanot s, morgan es, de kam ml, moerland m, romijn ja, cohen af, burggraaf j.
Characterization of a standardized glucagon challenge test as a pharmacodynamic tool in pharmacological research. Horm Metab Res. 2014 Apr;46(4):269-73. dillingh mr, van den blink b, moerland m, van dongen mg, levi m, kleinjan a, wijsenbeek ms, lupher ml jr, harper dm, getsy ja, hoogsteden hc, burggraaf j.
Recombinant human serum amyloid
P in healthy volunteers and patients with pulmonary fibrosis. Pulm
Pharmacol Ther. 2013 Dec;26(6):672-6.
moerland m, kales aj, schrier l, van dongen mg, bradnock d, burggraaf j.
Evaluation of the Endo pAt as a Tool to Assess Endothelial
Function. Int J Vasc Med. 2012;2012:904141.
van dongen mg*, geerts bf*, flameling b, moerland mm, de kam ml, cohen af, romijn ja, gerhardt cc, kloek j, burggraaf j.
Hydrolyzed casein decreases postprandial glucose concentrations in t2dm patients irrespective of leucine content. J Diet Suppl. 2011 Sep;8(3):280-92.
* both authors contributed equally to the manuscript.
bosscher d, rijken p, geerts bf, van dongen mg, de kam ml, cohen af, burggraaf j, gerhardt c, kloek j.
Dairy peptides in effective blood glucose management. Aus J Dairy Tech 2009; 64(1): 54-57 van dongen mg, kramer hm.
‘Informed consent’ en medische aansprakelijkheid. ntvg s 2004; 7(4); 66-7.
van dongen mg, moerland m, derks m, de kam ml, mazer na, romijn ja, cohen af, burggraaf j.
Metabolic responses to a glucagon challenge: comparison of healthy subjects and Type 2 Diabetes Mellitus patients with and without oral antidiabetic drugs. (Submitted) van dongen mg, alvarez-jimenez r, stevens j, peletier la, cohen af, burggraaf j.
Modeling the effect of a glucagon challenge on glucose homeostasis in humans. (Submitted) list of publications
115

Marloes van Dongen (1982; Woerden, the Netherlands) completed secondary education in 2000 (Atheneum) at R.S.G Broklede, Breukelen, The Netherlands.
Subsequently, she attended medical school at Leiden University Medical
Center ( lumc ) from which she graduated as Doctor of Medicine ( md) in 2006.
During her study she performed extra-curricular internships at the Department of Anatomy at Tygerberg hospital in Cape Town, South Africa (2004) and at the
Department of Obstetrics and Gynaecology at Diakonessenhuis in Paramaribo,
Surinam (2006).
From 2007 onwards she trained as a resident at the department of Internal
Medicine of the Medical Center Haaglanden in The Hague (head: dr. P.H.L.M.
Geelhoed-Duijvestijn). Marloes joined Centre for Human Drug Research ( chdr )
Leiden, in April 2008 to perform clinical research described in this thesis. This work was performed in collaboration with the department of Endocrinology of the Leiden University Medical Center ( lumc ), under the supervision of Prof. dr.
J. Burggraaf ( chdr ), Prof. dr. A.F. Cohen ( chdr ) and Prof. dr. J.A. Romijn ( lumc/ amc ). As part of her research training, she became a board certified Clinical
Pharmacologist in March 2012.
From 2011 onwards, she was admitted to the resident training program to become a specialist in Internal Medicine of which she completed the first part in 2014 at the department of Internal Medicine at Medical Center Haaglanden in The Hague (head: dr. A. Bootsma). She is currently completing her training program at the department of Internal Medicine at Leiden University Medical
Center (head: Prof. dr. J.W. de Fijter).
Marloes is married with Diederik van Rijn, they have one daughter Valérie and are expecting their second child.
exploring the role of glucagon in glucose homeostasis
116